Provider & product review
Synergy Rx NAD+ Review: Pricing, Terms and Evidence
Synergy Rx advertises NAD+ starting at $275. We review supply and renewal questions, refund terms, public disclosures and the clinical evidence.
Our verdict
Synergy Rx may appeal to someone seeking clinician-supervised NAD+ alongside other longevity offerings, but the current public catalog advertises a starting $275 rather than a complete patient-specific quote. Confirm the chosen term, amount paid upfront, supplied dose and renewal charge before enrolling. The older plan ladder discussed below needs confirmation for the selected offer.
The main practical concerns are the terms allowing costs to vary, unclear dose disclosure and conflicting refund language. Published clinician and pharmacy names are useful starting points for questions, not proof of a particular prescription or dispensing arrangement. The cited research does not establish that NAD+ injections improve focus or cognition.
On this page
The ladder
The current public products page advertises NAD+ injection starting at $275. An earlier catalog showed $275 month to month, $525 for three months ($175/month), $899 for six ($150/month) and $1,599 for twelve (about $133/month). These historical plan details are included for comparison, not as a currently confirmed offer; verify the selected term, supply and total before relying on them.
Earlier catalog prices — verify current plans
| Product | Month-to-month | 3 months | 6 months | 12 months |
|---|---|---|---|---|
| NAD+ injection | $275/mo | $525 ($175/mo) | $899 ($150/mo) | $1,599 ($133/mo) |
| Sermorelin injection | $275/mo | $525 | $899 | $1,599 |
| Glutathione injection | $275/mo | — | — | — |
| B-12 methylcobalamin | $109/mo | — | — | — |
| PT-141 | $275/mo | — | — | — |
Two things about that ladder deserve credit, and one of them is unusual enough to spell out.
First, the month-to-month rung exists and is stated. Across the providers we rank, a startling number publish only the twelve-month rung and print it with a "/mo" after it. Synergy publishes all four and lets you see which is which.
Second, the longevity ladder descends the way a ladder should — which is not true of Synergy's own weight-loss shelf. There, the compounded semaglutide "bundle" at three months works out at $249 a month against a $199 month-to-month rate. The bundle is more expensive than not bundling. We mention it because it is the same company's pricing logic, and because it means the word "bundle" carries no information here.
A starting $275 is a substantial commitment without knowing the supplied dose and billing period. Compare the final quote with other NAD+ providers, including fees and the total you must pay upfront.
The sentence that undoes the ladder
Synergy's terms contain this, verbatim: "the final charge to your credit card may fluctuate contingent upon the prescribed medication and the chosen pharmacy."
That is why a company publishing a complete four-rung price ladder sits where it does in our ranking rather than near the top of it. A published price is only worth what the seller's terms say it is worth, and Synergy has reserved the right to charge something else. It is not a hidden clause and it is not unique — but most operators who publish a ladder do not simultaneously disclaim it, and the ones we rank above Synergy either publish a firm number or tell you plainly what condition their number is attached to.
It gets sharper. Synergy's /about page advertises a "Money Back Guarantee". Its terms state that "medical consult fees are not subject to or eligible for a refund… all sales are final." Those are two of the company's own pages, and they say opposite things about the question a reader most wants answered. We are not going to adjudicate which one governs — that is the point. A guarantee that another page of the same site refuses is not a guarantee you can plan around.
Running alongside both: a "$100 welcome credit… no code needed" and a site-wide "2026 Promo Applied!" with no published terms anywhere, and a "Join 50,000+ SynergyRx patients" counter with nothing behind it.
Where it ships, and where it will not say
Where it operates. The terms say the service is "available to individuals located in certain states" and instruct you to contact customer service for the list. There is no list. Any claim you may have read that Synergy serves all fifty states is unsupported by anything the company publishes, and we do not repeat it.
What does exist is per-product shipping exclusions, which are more specific and more useful: glutathione, B-12 and the compounded skin creams are not shipped to Alabama, Arkansas, Alaska, Connecticut, Indiana, Kentucky, Louisiana, Michigan, Minnesota, Vermont or Wisconsin. NAD+ is served in those eleven — but through secondary pharmacies, with Synergy's own copy noting that "cost may vary". So for roughly a fifth of the country, the published $275 is explicitly not the number.
What it does tell you
Synergy's homepage FAQ names four dispensing pharmacies with phone numbers — Belmar, Strive, Epiq Scripts and Casa Pharma Rx — and two prescribing physicians with their NPI numbers: Dr. Ana Lisa Carr, MD (NPI 1689841744) and Dr. Kelly Tenbrink, MD (NPI 1346482684), through the clinical group Lion MD. An earlier NPPES check matched those identifiers; that is not current state-license or staff-assignment verification. Its `/about` page also publishes "Unlimited 24/7 Support Included… unlimited appointments, messaging and support".
The same pharmacy and clinician names appear on other CareValidate-backed sites, including Breeze Meds. Matching public text is not independent confirmation of the prescriber or pharmacy that will handle your order.
Published identifiers are useful for checking who will provide your care. Ask for the actual prescriber and pharmacy assigned to your order rather than inferring them from shared storefront text.
What it still will not tell you
Which of those four pharmacies fills your order. The names are published; the routing is not, and Synergy's own terms make the pharmacy a variable that can move the price.
What dose you get. No NAD+ or sermorelin strength is published anywhere, which is notable because Synergy's sibling brand on the same backend does publish a dose ladder. Synergy strips it. Without a milligram, $275 cannot be compared per unit against anything — which is the recurring hole in how NAD+ is priced across this category.
What Synergy publishes, and what it declines to
Confirm supply, final price, prescriber and refund terms
- An earlier search identified no warning letter naming the entities searched; this does not establish current compliance or safety.
- ✅ Names four pharmacies with phone numbers (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) and two physicians with NPIs (Dr Ana Lisa Carr 1689841744, Dr Kelly Tenbrink 1346482684, via Lion MD) — previously matched in NPPES; current licenses and staff assignment require confirmation.
- …but that text is byte-identical to its CareValidate siblings', Breeze Meds included, so it is shared white-label copy and never independent corroboration of another brand's bench.
- Terms: “the final charge to your credit card may fluctuate contingent upon the prescribed medication and the chosen pharmacy” — so the published ladder is not binding.
- /about advertises a “Money Back Guarantee”; the terms say consult fees are non-refundable and all sales are final.
- Not published: the states served, which of the four pharmacies fills a given order, and any NAD+ dose or strength.
- Glutathione, B-12 and the skin creams do not ship to 11 states; NAD+ ships there via secondary pharmacies, where Synergy's own copy says cost may vary.
The PT-141 page, which tells you something about the whole catalog
Synergy sells PT-141 at $275, and its product description reads: "PT-141 is a peptide that increases the body's natural production of growth hormone (GH)… increased lean muscle mass, decreased body fat, improved sleep."
That is not what PT-141 is. PT-141 — bremelanotide — is a melanocortin receptor agonist studied and marketed for sexual dysfunction. It is not a growth-hormone secretagogue and it does not do any of the things that sentence promises. The text is Synergy's sermorelin description, pasted onto the wrong molecule.
We name it rather than repeat it, and we raise it on a page about NAD+ for one reason: it is evidence about how the product copy on this site is produced. A catalog where one product's description has been pasted onto another is a catalog where the descriptions have not been read. That is worth knowing before trusting the NAD+ page's account of what NAD+ does — and it is the same failure another company we rank made, in the same direction, on its own NAD+ page describing a different molecule entirely.
Some product and FAQ text is shared across CareValidate-backed brands. For a buyer, the practical implication is to confirm the details of this specific prescription rather than treating matching text on another storefront as a second clinical opinion.
What checks out
Public disclosures and regulatory searches have different limits.
An earlier FDA-index search did not identify a warning letter naming Synergy Rx or the entities searched alongside it. This is a limited search observation, not a certification of safety, licensing or current regulatory compliance.
The evidence on cognition
No rigorous human trial shows that injected NAD+ improves cognition, focus or energy. That is our position for every company we rank. In older adults with mild cognitive impairment, oral nicotinamide riboside raised NAD+ and did not improve cognition versus placebo1; a second randomized trial in subjective cognitive decline and mild cognitive impairment found no cognitive benefit2; and the only human data on a parenteral route is a pilot that tracked NAD+ metabolites through a six-hour infusion and measured no cognitive outcome at all3.
The long version is in our review of the NAD+ cognition evidence, and the compounded preparations sold here are not FDA-approved products — a compounded drug is not a generic equivalent of an approved one4.
The bottom line
Synergy Rx advertises NAD+ starting at $275 and publishes clinician and pharmacy information. Before paying, confirm the selected supply, renewal terms, dispensing pharmacy and which charges are refundable. Neither public names nor an absence of an identified warning letter proves product quality.
The unresolved details matter more than the number of products offered. Get a written quote for the dose and supplied period, the final price in your state, renewal terms and any refundable charges. If a marketing guarantee conflicts with checkout terms, resolve that before enrolling.
A few gentle questions
How much does Synergy Rx NAD+ cost?
The NAD+ injection is $275 a month, month to month. The longer rungs are $525 for three months ($175/mo), $899 for six ($150/mo) and $1,599 for twelve ($133/mo). Glutathione and sermorelin injections are also $275 and a B-12 injection is $109. No dose or strength is published for any of them.
Is Synergy Rx's published price the price you are charged?
Not necessarily, by the company's own terms: “the final charge to your credit card may fluctuate contingent upon the prescribed medication and the chosen pharmacy.” Separately, NAD+ shipped into the eleven states its other longevity products cannot reach is filled by secondary pharmacies, where Synergy's own copy says cost may vary. So the published ladder is a starting point rather than a commitment.
Does Synergy Rx offer a money-back guarantee?
Its /about page says so. Its terms say the opposite — that medical consult fees are not eligible for a refund and that all sales are final. Two pages of the same site disagree, and we are not going to guess which governs. Treat it as unresolved rather than as a guarantee you can plan around.
Which states does Synergy Rx serve?
It does not publish a list. Its terms say the service is available in “certain states” and tell you to contact customer service. What it does publish is per-product exclusions: glutathione, B-12 and its skin creams do not ship to Alabama, Arkansas, Alaska, Connecticut, Indiana, Kentucky, Louisiana, Michigan, Minnesota, Vermont or Wisconsin. NAD+ is served in those eleven through secondary pharmacies, at a cost Synergy says may vary.
Who prescribes for Synergy Rx, and which pharmacy fills it?
The reviewed homepage FAQ named Dr. Ana Lisa Carr and Dr. Kelly Tenbrink with NPI numbers, and four pharmacies: Belmar, Strive, Epiq Scripts and Casa Pharma Rx. These are public disclosures, not current licensing or staff-assignment verification. Ask which prescriber and pharmacy will handle your prescription; matching names on another storefront do not independently confirm that arrangement.
Does Synergy Rx have an FDA warning letter?
An earlier search did not identify a warning letter naming Synergy or the entities searched alongside it. That limited observation is not current regulatory clearance, license verification or proof of product safety.
Why does Synergy's PT-141 page describe growth hormone?
Because it is the wrong text. Synergy's PT-141 description claims the product raises natural growth hormone and delivers lean muscle, less body fat and better sleep — that is its sermorelin copy pasted onto a different molecule. PT-141 (bremelanotide) is a melanocortin agonist studied for sexual dysfunction and does none of those things. We name the error rather than repeat the claim, and we mention it on an NAD+ page because it tells you how carefully the product copy on this site is written.
Are Synergy Rx, Care Bare Rx and Breeze Meds the same company?
They are different storefronts using the CareValidate platform. Shared product or FAQ text should not be treated as a second clinical opinion or independent confirmation of your prescription details.
Where this comes from
- Orr ME, Kotkowski E, Ramirez P, Bair-Kelps D, Liu Q, Brenner C, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024;46(1):665-682. https://pubmed.ncbi.nlm.nih.gov/37994989/
- Wu CY, Kupferschmid AC, Chen L, McManus AJ, Kivisäkk P, Galler JA, et al. (2025). Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement (N Y). 2025;11(1):e70023. https://pubmed.ncbi.nlm.nih.gov/39817194/
- Grant R, Berg J, Mestayer R, Braidy N, Bennett J, Broom S, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. https://pubmed.ncbi.nlm.nih.gov/31572171/
- U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA, Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Read on, gently
MyDrHank NAD+ Review: Starting Price, Care and Plan Questions
MyDrHank advertises NAD+ from $137/month, depending on protocol and dose. Compare included care, renewal questions, pharmacy disclosures and evidence limits.
ReadWillow NAD+ Review: $199 Plan, Supply, and Support
Willow advertises NAD+ injections at $199/month. We review the schedule, support, pharmacy disclosures, subscription caveats, and cognitive evidence.
ReadOak NAD+ Review: Published Pricing, Included Care and Questions
Oak now advertises NAD+ injections from $175/month. Review included care, the regular $199 price, pharmacy questions and the limits of the evidence.
ReadCoreAge Rx NAD+ Review: $93 Starting Price, Refund Fine Print
CoreAge Rx offers nasal and injectable NAD+ from $93/month. We check the price wording, refund exclusions, care model, and brain-fog evidence.
ReadLttl NAD+ Review: Monthly Pricing, Prepaid Plans and Evidence
Lttl NAD+ costs $149 on the monthly plan. Compare its $99 introduction, prepaid commitments, pharmacy disclosures and the limits of the brain-fog evidence.
ReadPallas Health NAD+ Review: Four-Week Pricing and Care
Pallas NAD+ injection lists $139 initially, then $179 every four weeks. Understand the renewal cadence, annual-plan headline, included care and evidence limits.
Read